Patient nonadherence to medication in inflammatory bowel disease

American Journal of Gastroenterology

Volumn 98, Issue 7, 2003, Pages 1535-1544

  Sewitch, Maida J ^a   Abrahamowicz, Michal ^b   Barkun, Alan ^b   Bitton, Alain ^b   Wild, Gary E ^b   Cohen, Albert ^b   Dobkin, Patricia L ^b  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DISEASE ACTIVITY; DISEASE COURSE; DOCTOR PATIENT RELATION; ENTERITIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTPATIENT; PATIENT ATTITUDE; PATIENT COMPLIANCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SOCIAL PSYCHOLOGY; WELLBEING;

EID: 0037707373     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2003.07522.x     Document Type: Article

References (84)

1. Botoman VA, Bonner GF, Botoman DA. Management of inflammatory bowel disease. Am Fam Phys 1998;57:57-68.
2. Hanauer SB, Baert FJ. The management of ulcerative colitis. Annu Rev Med 1995;46:497-505.
3. Brinberg DE, Berkeley BE. Crohn's disease. A comprehensive approach to management. Postgrad Med 1989;86:257-265.
4. Kane S. Patient compliance and outcomes. Inflamm Bowel Dis 1999;5:134-7.
5. Farup PG, Hovde O, Halvorsen FA, et al. Melsalazine suppositories versus hydrocortisone foam in patients with distal ulcerative colitis. A comparison of the efficacy and practicality of two topical treatment regimens. Scand J Gastroenterol 1995;30:164-70.
6. Mesalamine Study Group. An oral preparation of mesalamine as long-term maintenance therapy for ulcerative colitis. A randomized, placebo-controlled trial. The Mesalamine Study Group. Ann Intern Med 1996;124:204-11.
7. Greenberg GR, Feagan BG, Martin F, and the Canadian Inflammatory Bowel Disease Study Group. Oral budesonide for active Crohn's disease. N Engl J Med 1994;331:836-41.
8. Feagan BG, Fedorak RN, Irvine EJ, for the North American Crohn's Study Group Investigators. A comparison of methotrexate with placebo for the maintenance of remission in Crohn's disease. N Engl J Med 2000;342:1627-32.
9. Rosen A, Ursing B, Alm T, et al. A comparative study of metronidazole and sulfasalazine for active Crohn's disease: The cooperative Crohn's disease study in Sweden. I. Design and methodologic considerations. Gastroenterology 1982;83:541-9.
10. Feagan B. Infliximab in the treatment of Crohn's disease. Can J Gastroenterol 2000;14:6C.
11. Steinhart H. Maintenance therapy in Crohn's disease. Can J Gastroenterol 2001;14:23-8C.
12. Riley SA, Mani V, Goodman MJ, Lucas S. Why do patients with ulcerative colitis relapse? Gut 1990;31:179-83.
13. van Hees PA, van Tongeren JH. Compliance to therapy in patients on a maintenance dose of sulfasalazine. J Clin Gastroenterol 1982;4:333-6.
14. Kane SV, Cohen RD, Aikens JE, Hanauer SB. Prevalence of nonadherence with maintenance mesalamine in quiescent ulcerative colitis. Am J Gastroenterol 2001;96:2929-33.
15. DiMatteo MR. Adherence to treatment. In: Feldman MD, Christensen JF, eds. Behavioral medicine. A primary care handbook. New York: Appleton & Lange, 1997:136-40.
16. Nigro G, Angelini G, Grosso SB, et al. Psychiatric predictors of noncompliance in inflammatory bowel disease. Psychiatry and compliance. J Clin Gastroenterol 2001;32:66-8.
17. Haynes RB. Determinants of compliance: The disease and the mechanism of treatment. In: Haynes RB, Taylor DW, Sackett DL, eds. Compliance in health care. Baltimore: Johns Hopkins University Press, 1979.
18. Noble LM. Doctor-patient communication and adherence to treatment. In: Myers LB, Midence K, eds. Adherence to treatment in medical conditions. New York: Harwood Academic Publishers, 1998:51-82.
19. Agras WS. Understanding compliance with the medical regimen: The scope of the problem and a theoretical perspective. Arthritis Care Res 1989;2:S2-7.
20. Spiro H. Compliance, adherence, and hope. J Clin Gastroenterol 2001;32:5.
21. Roter DL, Hall JA, Merisca R, et al. Effectiveness of interventions to improve patient compliance. A meta-analysis. Med Care 1998;36:1138-61.
22. Carr AJ, Donovan JL. Why doctors and patients disagree. Br J Rheumatol 1998;37:1-6.
23. Haynes RB, Taylor DW, Snow JC, Sackett DL. Annotated and indexed bibliography on compliance with therapeutic and preventive regimens. In: Haynes RB, Taylor DW, Sackett DL, eds. Compliance in health care. Baltimore: Johns Hopkins University Press, 1979:337-474.
24. Dunbar J. Predictors of patient adherence: Patient characteristics. In: Shumaker SA, Schron EB, Ockene JK, eds. The handbook of health behavior change. New York, Spring Publishing Co, 1990:348-60.
25. Golin CE, DiMatteo MR, Gelberg L. The role of patient participation in the doctor visit. Implications for adherence to diabetes care. Diabetes Care 1996;19:1153-64.
26. Stewart MA, McWhinney IR, Buck CW. The doctor/patient relationship and its effect upon outcome. J R Coll Gen Pract 1979;29:77-82.
27. Bass MJ, Buck C, Turner L, et al. The physician's actions and the outcome of illness in family practice. J Fam Pract 1986;23:43-7.
28. Starfield B, Steinwachs D, Morris I, et al. Patient-doctor agreement about problems needing follow-up visit. JAMA 1979;242:344-6.
29. Starfield B, Wray C, Hess K, et al. The influence of patient-practitioner agreement on outcome of care. Am J Public Health 1981;71:127-31.
30. Berkanovic E, Hurwicz M-L, Lachenbruch PA. Concordant and discrepant views of patients' physical functioning. Arthritis Care Res 1995;8:95-101.
31. Chesney AP, Brown KA, Poe CW, Gary HE. Physician-patient agreement on symptoms as a predictor of retention in outpatient care. Hosp Com Psychiatry 1983;34:737-9.
32. Taylor RB, Burdette JA, Camp L, Edwards J. Purpose of the medical encounter: Identification and influence on process and outcome in 200 encounters in a model family practice center. J Fam Pract 1980;10:495-500.
33. Fagerberg CR, Kragstrup J, Stovering H, Rasmussen NK. How well do patient and general practitioner agree about the content of consultations? Scand J Prim Health Care 1999;17:149-52.
34. Himmel W, Lippert-Urbanke E, Kochen MM. Are patients more satisfied when they receive a prescription? The effect of patient expectations in general practice. Scan J Prim Health Care 1997;15:118-22.
35. Murden RA, Kreger CG. Patient-physician agreement on reasons for outpatient visits. Mayo Clin Proc 1999;74:105-6.
36. Boland BJ, Scheitel SM, Wollan PC, Silverstein MD. Patient-physician agreement on reasons for ambulatory general medical examinations. Mayo Clin Proc 1998;73:109-17.
37. Wartman SA, Morlock LL, Malitz FE, Palm E. Impact of divergent evaluations by physicians and patients of patient complaints. Public Health Rep 1983;98:141-5.
38. Coronary Drug Project Research Group. Influence of adherence to treatment and response of cholesterol on mortality in the coronary drug project. N Engl J Med 1980;303:1038-41.
39. Irvine J, Baker B, Smith J, et al. Poor adherence to placebo or amiodarone therapy predicts mortality: Results from the CAMIAT Study. Psychosom Med 1999;61:566-75.
40. Horowitz RI, Viscoli CM, Berkman L, et al. Treatment adherence and risk of death after a myocardial infarction. Lancet 1980;336:542-5.
41. Francis V, Korsch BM, Morris MJ. Gaps in doctor-patient communication. Patients' response to medical advice. N Engl J Med 1969;280:535-40.
42. Sherbourne CD, Hays RD, Ordway L, et al. Antecedents of adherence to medical recommendations: Results from the Medical Outcomes Study. J Behav Med 1992;15:447-68.
43. Wurtemberger G, Hutter BO. Health-related quality of life, psychological adjustment and compliance to treatment in patients on domiciliary liquid oxygen. Monaldi Arch Chest Dis 2000;55:216-24.
44. Oermann CM, Swank PR, Sockrider MM. Validation of an instrument measuring patient satisfaction with chest physiotherapy techniques in cystic fibrosis. Chest 2000;118:92-7.
45. Weingarten SR. A study of patient satisfaction and adherence to preventive care practice guidelines. Am J Med 1995;99:590-6.
46. Frank S, Zyzanski S, Alemagno S. Upper respiratory infection: Stress, support and the medical encounter. Fam Med 1992;24:518-23.
47. Drossman DA, Leserman J, Mitchell M, et al. Health status and health care use in persons with inflammatory bowel disease. A national sample. Dig Dis Sci 1991;36:1746-55.
48. Drossman DA, Leserman J, Li Z, et al. The rating form of IBD patient concerns: A new measure of health status. Psychosom Med 1991;53:701-12.
49. Dobkin PL, Fortin PR, Joseph L, et al. Psychosocial contributors to mental and physical health in patients with systemic lupus erythematosus. Arthritis Care Res 1998;11:23-31.
50. Derogatis LR. SCL-90-R. Symptom Checklist-90-R. Administration, scoring, and procedures manual, 3rd ed. Minneapolis: National Computer Systems, 1994.
51. Kimmel PL, Peterson RA, Weihs KL, et al. Behavioral compliance with dialysis prescription in hemodialysis patients. J Am Soc Nephrol 1995;10:1826-34.
52. Drossman DA. Psychosocial factors in ulcerative colitis and Crohn's disease. In: Kirsner JB, ed. Inflammatory bowel disease. Philadelphia: WB Saunders, 1998:492-513.
53. Meichenbaum D, Turk DC. Facilitating treatment adherence. New York: Plenum Press, 1987.
54. Horne R. Adherence to medication: A review of existing research. In: Myers LB, Midence K, eds. Adherence to treatment in medical conditions. New York: Harwood Academic Publishers, 1998:285-310.
55. Sewitch MJ, Abrahamowicz M, Bitton A, et al. Psychosocial correlates of patient-physician discordance in inflammatory bowel disease. Am J Gastroenterol 2002;97:2174-83.
56. Sewitch MJ, Abrahamowicz M, Dobkin P, et al. Measuring differences between patients' and physicians' perceptions: The Patient-Physician Discordance Scale. J Behav Med 2003;26:245-64.
57. Sarason IG, Sarason BR, Shearin EN, Pierce GR. A brief measure of social support: Practical and theoretical implications. J Soc Pers Relationships 1987;4:497-510.
58. Sarason IG, Levine HM, Basham RB, Sarason BR. Assessing social support: The social support questionnaire. J Pers Soc Psychol 1983;44:127-39.
59. Cohen S, Williamson GM. Perceived stress in a probability sample of the United States. In: Spacapan S, Oskamp S, eds. The social psychology of health. Newbury Park, CA: Sage Publications. 1988:31-67.
60. Brantley PJ, Jones GN, Boudreaux E, Catz S. Weekly stress inventory. In: Zalaquett CP, Wood RJ, eds. Evaluating stress: A book of resources. Lanham, MD: Scarecrow Press, 1997:405-20.
61. Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care 1986;24:67-74.
62. Cronbach LJ. Coefficient alpha and the internal structure of tests. Psychometrika 1951;16:297-334.
63. Kravitz RL, Hays RD, Sherbourne CD, et al. Recall of recommendations and adherence to advice among patients with chronic medical conditions. Arch Intern Med 1993;153:1869-78.
64. Choo PW, Rand CS, Inui TS, et al. Validation of patient reports, automated pharmacy records, and pill counts with electronic monitoring of adherence to antihypertensive therapy. Med Care 1999;37:846-57.
65. Blomqvist P, Feltelius N, Lofberg R, Ekbom A. A 10-year survey of inflammatory bowel diseases-drug therapy, costs and adverse reactions. Aliment Pharmacol Ther 2001;15:475-81.
66. Harvey RF, Bradshaw JM. A simple index of Crohn's disease activity. Lancet 1980;1:514.
67. Greenbloom SL, Steinhart AH, Greenberg GR. Combination of ciprofloxacin and metronidazole for active Crohn's disease. Can J Gastroenterol 1998;12:53-6.
68. Lehmann M, Chamiot-Prieur C, Mesnard B, et al. Methotrexate for the treatment of refractory Crohn's disease. Aliment Pharmacol Ther 1996;10:309-14.
69. Mahmud N, McDonald GS, Kelleher D, Weir DG. Microalbuminuria correlates with intestinal histopathological grading in patients with inflammatory bowel disease. Gut 1996;38:99-103.
70. Sewitch MJ, Abrahamowicz M, Bitton A, et al. Psychological distress, social support and disease activity in patients with inflammatory bowel disease. Am J Gastroenterol 2001;96:1470-9.
71. Liang K-Y, Zeger SL. Longitudinal data analysis using generalized linear models. Biometrika 1986;73:13-22.
72. The GENMOD procedure; SAS/STAT Software: Changes and enhancements for release 6.12. Cary, NC: SAS Institute, 1996:23-42.
73. Akaike H. A new look at statistical model identification. IEEE Trans Autom Control 1974;19:716-23.
74. DiMatteo MR, Sherbourne CD, Hay RD, et al. Physicians' characteristics influence patients' adherence to medical treatment: Results from the Medical Outcomes Study. Health Psychol 1993;12:93-102.
75. Liu H, Kaplan A, Wenger N. Measuring patient adherence. Ann Intern Med 2002;137:E-72-3.
76. Hays RD, DiMatteo MR. Key issues and suggestions for patient compliance assessment: Sources of information, focus of measures, and nature of response options. J Compliance Health Care 1987;2:37-53.
77. Haynes RB, Taylor DW, Sackett D, et al. Can simple clinical measurements detect patient noncompliance? Hypertension 1980;2:757-64.
78. DiMatteo MR, Hays RD. Adherence to cancer regimens: Implications for treating the older patient. Oncology 1992;6:50-7.
79. Lieberman JR, Dorey F, Shekelle P, et al. Differences between patients' and physicians' evaluations of outcome after total hip arthroplasty. J Bone Joint Surg 1996;78:835-8.
80. Connelly JE, Philbrick JT, Smith GR Jr, et al. Health perceptions of primary care patients and the influence on health care utilization. Med Care 1989;27:S99-109.
81. Temple W, Toews J, Fidler H, et al. Concordance in communication between surgeon and patient. Can J Surg 1998;41:445.
82. Neville C, Clarke AE, Joseph L, et al. Learning from discordance in patient and physician global assessments of systemic lupus erythematosus disease activity. J Rheumatol 2000;27:675-8.
83. Boyer BA, Lerman C, Shipley TEJ, et al. Discordance between physician and patient perceptions in the treatment of diabetes mellitus: A pilot study of the relationship to adherence and glycemic control. Diabetes Educator 1996;22:493-9.
84. Turner BJ, Hect FM. Improving on a coin toss to predict patient adherence to medications. Ann Intern Med 2001;134:1004-6.